Holen Sie sich die Stockscreener-App
0.1447
26.24%
-0.0504
Schlusskurs vom Vortag:
$0.1951
Offen:
$0.15795
24-Stunden-Volumen:
2.95M
Relative Volume:
2.43
Marktkapitalisierung:
$128.43K
Einnahmen:
$3,200
Nettoeinkommen (Verlust:
$-42.79M
KGV:
-0.000019
EPS:
-7534.7458
Netto-Cashflow:
$-25.70M
1W Leistung:
-42.21%
1M Leistung:
-81.89%
6M Leistung:
-99.65%
1J Leistung:
-99.99%
1-Tages-Spanne:
$0.117
$0.1611
1-Wochen-Bereich:
$0.117
$0.2294
52-Wochen-Spanne:
$0.117
$2,495.04
Aditxt Inc Stock (ADTX) Company Profile
Firmenname
Aditxt Inc
Sektor
Branche
Telefon
909-488-0844
Adresse
737 N. FIFTH STREET, SUITE 200, RICHMOND
Compare ADTX vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADTX
Aditxt Inc
|
0.142 | 176.46K | 3,200 | -42.79M | -25.70M | -7,534.75 |
VRTX
Vertex Pharmaceuticals Inc
|
426.25 | 107.83B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
709.03 | 73.54B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
800.26 | 48.72B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
294.67 | 39.51B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
298.01 | 32.66B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aditxt Inc Aktie (ADTX) Neueste Nachrichten
ADTX - Finviz
Aditxt Shareholders Approve Reverse Split and Governance Measures - The Globe and Mail
Aditxt, Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Nasdaq Listing Information - Minichart
Aditxt (ADTX) investors approve reverse split authority and elect full board - Stock Titan
ADTX Stock Price, Quote & Chart | ADITXT INC (NASDAQ:ADTX) - ChartMill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
HRT Financial LP sells $9,338 in Aditxt stock By Investing.com - Investing.com Australia
HRT Financial LP sells $9,338 in Aditxt stock - Investing.com
HRT Financial LP trims Aditxt (NASDAQ: ADTX) stake with open-market sales - Stock Titan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket - Benzinga
HRT Financial buys $24,060 Aditxt shares, sells $3,594 By Investing.com - Investing.com India
148.3M Warrant Shares Registered for Resale by Aditxt (NASDAQ: ADTX) - Stock Titan
HRT Financial buys $24,060 Aditxt shares, sells $3,594 - Investing.com
Ten percent owner HRT Financial LP trades Aditxt (ADTX) Class A shares - Stock Titan
HRT Financial LP reports insider stake in Aditxt, Inc. (ADTX) on Form 3 - Stock Titan
Aditxt announces 1-for-8 reverse stock split - MSN
ADTX (Aditxt Inc.) shares drop 3.13% following its steeply unprofitable Q3 2025 quarterly earnings release.Buy Rating - Xã Thanh Hà
ADTX (Aditxt Inc.) reports Q3 2025 earnings, shares post small gains amid limited available financial metrics.Sector Outperform - UBND thành phố Hải Phòng
[EFFECT] Aditxt, Inc. SEC Filing - Stock Titan
Aditxt (ADTX) Precision Oncology Subsidiary Featured in Key Canc - GuruFocus
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Aditxt (ADTX) Stock Stock Repair (Trend Weakens) 2026-04-20Community Breakout Alerts - Xã Thanh Hà
Standard HER2 test fell short as Dana-Farber assessed Enhertu outcomes - Stock Titan
Aditxt announces $1.25 million private placement of senior unsecured notes By Investing.com - Investing.com South Africa
Aditxt Announces New Note Financing and Debt Obligations - TipRanks
Aditxt announces $1.25 million private placement of senior unsecured notes - Investing.com
Debt financing: Aditxt (NASDAQ: ADTX) sells $1.25M senior notes - Stock Titan
Illinois Pharmacists Can Prescribe PHEXXI Starting January 2026 Under Newly-passed Law - ADVFN
Aditxt (NASDAQ: ADTX) registers 148.3M shares issuable on warrants - Stock Titan
Aditxt, Inc. announced that it has received $1 million in funding - marketscreener.com
Is Aditxt (ADTX) Stock trading above fair value | Price at $0.52, Up 0.19%Top Trending Breakouts - Cổng thông tin điện tử Tỉnh Sơn La
Ignite Proteomics LLC Reports 2025 Financial Results and Acquisition by Aditxt, Inc - Minichart
12 Health Care Stocks Moving In Tuesday's Intraday Session - Sahm
Bull Bear: Can Aditxt Inc grow without dilution2026 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn
Ignite deal: Aditxt (NASDAQ: ADTX) records $36,551K goodwill - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market SessionAditxt (NASDAQ:ADTX), Advanced Biomed (NA - Benzinga
Will Aditxt (ADTX) Stock Outperform S&P 500 | Price at $0.61, Down 22.71%Low Risk Entry - Xã Thanh Hà
Setup Watch: Can Aditxt Inc grow without external funding2026 Setups & Long-Term Safe Investment Plans - baoquankhu1.vn
ADTX | Aditxt, Inc. Common Stock Executive Compensation - Quiver Quantitative
Aditxt (NASDAQ: ADTX) seeks reverse stock split and say-on-pay nod - Stock Titan
Aditxt regains compliance with Nasdaq listing standards following equity increase - Investing.com
Aditxt regains Nasdaq compliance after equity rises to $3.95M - TradingView — Track All Markets
Aditxt (NASDAQ: ADTX) back in line with Nasdaq equity listing rules - Stock Titan
ADTX Stock Analysis: Aditxt Inc. Drops 8.06% to $0.9 Key Technical Support Level - Cổng thông tin điện tử tỉnh Lào Cai
Aditxt 10-K: Revenue $0.003M, Net loss $42.79M, EPS $(1,153.83) - TradingView — Track All Markets
Heavy losses and Nasdaq risk at Aditxt (NASDAQ: ADTX) in 2025 10-K - Stock Titan
Aditxt, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Finanzdaten der Aditxt Inc-Aktie (ADTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Aditxt Inc-Aktie (ADTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10% Owner |
Apr 23 '26 |
Sale |
0.29 |
3,811 |
1,105 |
117,781 |
| HRT FINANCIAL LP | 10% Owner |
Apr 21 '26 |
Buy |
0.33 |
72,912 |
24,061 |
133,574 |
| HRT FINANCIAL LP | 10% Owner |
Apr 22 '26 |
Sale |
0.30 |
11,982 |
3,595 |
121,592 |
| Brady Brian Michael | Director |
Dec 17 '25 |
Sale |
1.75 |
1 |
2 |
3 |
| Pankovcin Corinne | Chief M&A Officer |
Nov 25 '25 |
Sale |
3.20 |
1 |
3 |
0 |
0.83%
2.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):